Pregnancy Labeling Changes May Spur Research, FDA Says
This article was originally published in The Pink Sheet Daily
Executive Summary
Final regulation eliminates use of letter-based categories to designate level of risk during pregnancy and lactation; in a change from the 2008 proposed rule, information relevant to drug effects on reproductive potential will now be housed in dedicated section.